September 4, 2023 Nestlé announced today that is has divested Palforzia, its peanut allergy treatment business, to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of … More Nestlé divests its Palforzia business

Bern, 04.09.2023 Following on from a robust first quarter (+0.9 %), Switzerland’s GDP adjusted for sporting events remained flat in the second quarter of 2023 (+0.0 %).* Industry saw a decline … More SECO: Gross domestic product in the second quarter of 2023: Swiss economy stagnates